HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Deals

Boehringer Ingelheim to expand its AI footprint in UK, in £150M investment

LONDON – Boehringer Ingelheim is growing its artificial intelligence arm to the UK by building a new hub in central London and investing £150 million over the next 10 years. The AI hub will be ...

By Endpoints News · Apr 20, 2026 · via Endpoints News
Boehringer Ingelheim to expand its AI footprint in UK, in £150M investment

Image: Endpoints News

Tags
dealsformat:headlineheadlineEndpoints News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Deals
All Deals →
Lilly picks up another in vivo CAR-T company with Kelonia buyout worth up to $7B
DealsFierceBiotech ↗
Lilly picks up another in vivo CAR-T company with Kelonia buyout worth up to $7B
Eli Lilly is picking up its second in vivo CAR-T company of the year, paying $3.25 billion in upfront cash for…
Apr 21, 2026
Asahi Kasei acquires German company Aicuris
DealsPharmaceutical Technology ↗
Asahi Kasei acquires German company Aicuris
Asahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company.…
Apr 21, 2026
Lilly Bets $3.25B on Kelonia to Push In‑Vivo CAR‑T from Concept to Platform
Deals
Lilly Bets $3.25B on Kelonia to Push In‑Vivo CAR‑T from Concept to Platform
Lilly’s $3.25 billion upfront acquisition of Kelonia Therapeutics signals a bold move into in‑vivo CAR‑T techn…
Apr 20, 2026